RecruitingPhase 1NCT07230600

AD-SVF Therapy for Refractory Endometrial Infertility

Autologous Adipose-derived Stromal Vascular Fraction Therapy for Refractory Endometrial Infertility

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Enrollment

10 participants

Start Date

Nov 1, 2025

Study Type

INTERVENTIONAL

Conditions

Endometrium; Atrophy Intrauterine Synechiae

Summary

The purpose of this study is to initially explore the efficacy of adipose-derived stromal vascular fraction (AD-SVF) therapy in the treatment of refractory endometrial infertility.

Eligibility

Sex: FEMALEMin Age: 22 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called AD-SVF for people with endometrium; atrophy and intrauterine synechiae. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 22 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAD-SVF

AD-SVF is isolated and extracted from adipose tissue for intrauterine infusion therapy.

Locations(1)

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07230600